HPV in Head and Neck Cancer, Part 1: What is it and What Does it Mean? (audio)
7m
·
GRACEcast Head and Neck Cancer Audio
·
GRACE, cancerGRACE, GRACEcast, Jared Weiss, Unveristy of North Carolina-Chapel Hill, UNC-Chapel Hill, induction therapy, neoadjuvant therapy, head and neck cancer, HNSCC, carbplatin, paclitaxel, cetuximab, Taxol, Erbitux, weekly
The episode HPV in Head and Neck Cancer, Part 1: What is it and What Does it Mean? (audio) from the podcast GRACEcast Head and Neck Cancer Audio has a duration of
7:32. It was first published
More episodes from GRACEcast Head and Neck Cancer Audio
Late Stage Oropharynx Cancer, Chemotherapy - Options and Practice (audio)
Dr. Jared Weiss, University of North Carolina, discusses chemotherapy options and practice in late stage oropharynx cancer.
Late Stage Oropharynx Cancer, Treatment and Side Effects (audio)
Dr. Geoffrey Geiger, University of Pennsylvania, outlines the course of radiotherapy treatment and side effects for head and neck cancer.
Late Stage Oropharynx Cancer, Planning for External Beam Radiotherapy (audio)
Dr. Geoffrey Geiger, University of Pennsylvania, discusses the process of planning radiotherapy for head and neck cancer.
Late Stage Oropharynx Cancer, Introduction and Management (audio)
Dr. Geoffrey Geiger, University of Pennsylvania, provides an introduction to head and neck cancer and the human papilloma virus.
HPV in Head and Neck Cancer, Part 2: Caveats and Emerging Trials (audio)
Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population.